Neuromodulation for Metabolic Dysfunction

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT07597161

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose other
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Rahul Sachdeva (from the registry)
Registry
  • NCT NCT07597161
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07597161. Randomized; single masking; primary purpose other. Start 2026-10-20 (actual); primary completion 2030-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Neuromodulation for Metabolic Dysfunction
Condition
Spinal Cord Injuries (SCI)
Condition
Prediabetes / Type 2 Diabetes
Intervention (Device)
Transcutaneous Spinal Cord Stimulation (tSCS)
Intervention (Device)
Sham transcutaneous spinal cord stimulation (tSCS)
Lead sponsor
Rahul Sachdeva (class: other)

Record details

Record id
cardio:ct-nct07597161
Content hash
e66edfeebb5b3142fa3bdd91464ce963c0528211543e3ba31152884ef704b7e5